Alkermes plc (8AK)
FSX
Real-time Data
06:00 AM
Day's Range
36.6352 wk Range
23.20Profile - 8AK - Alkermes plc
Profile
Mic Code
XFRA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2.05K
Alkermes plc is a global biopharmaceutical company focused on developing, manufacturing, and commercializing medicines for central nervous system disorders and other serious conditions. Its current portfolio includes treatments for schizophrenia, bipolar I disorder, alcohol dependence, opioid dependence, and narcolepsy-related symptoms, with products such as ARISTADA, ARISTADA INITIO, VIVITROL, LYBALVI, and LUMRYZ. The company works across research, clinical development, and product commercialization, using its drug formulation and delivery capabilities to support therapies designed for complex and chronic illnesses. Alkermes plc serves patients, healthcare providers, and healthcare systems in the United States, Ireland, and international markets. Founded in 1987 and headquartered in Dublin, Ireland, the company holds a notable position in the neuroscience-focused biopharmaceutical sector.
Profile Details
Type
Common Stock
Address
Connaught House
City
Dublin
Zip
D04 C5Y6
Country
Ireland
Phone
353 1 772 8000
Key Executives - 8AK - Alkermes plc
Key executives
Cross Listings - 8AK - Alkermes plc
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
